The Watchmen

STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial

STAT · September 30, 2026
STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
Source:STAT

Comments

No comments yet.

Sign in to join the conversation.

Sign In
Read original article